Literature DB >> 22293986

Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.

Vanessa H Brait1, Thiruma V Arumugam, Grant R Drummond, Christopher G Sobey.   

Abstract

Following an ischemic stroke, T lymphocytes become activated, infiltrate the brain, and appear to release cytokines and reactive oxygen species to contribute to early inflammation and brain injury. However, some subsets of T lymphocytes may be beneficial even in the early stages after a stroke, and recent evidence suggests that T lymphocytes can also contribute to the repair and regeneration of the brain at later stages. In the hours to days after stroke, T-lymphocyte numbers are then reduced in the blood and in secondary lymphoid organs as part of a 'stroke-induced immunodeficiency syndrome,' which is mediated by hyperactivity of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis, resulting in increased risk of infectious complications. Whether or not poststroke T-lymphocyte activation occurs via an antigen-independent process, as opposed to a classical antigen-dependent process, is still controversial. Although considerable recent progress has been made, a better understanding of the roles of the different T-lymphocyte subpopulations and their temporal profile of damage versus repair will help to clarify whether T-lymphocyte targeting may be a viable poststroke therapy for clinical use.

Entities:  

Mesh:

Year:  2012        PMID: 22293986      PMCID: PMC3318155          DOI: 10.1038/jcbfm.2012.6

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  134 in total

1.  Fingolimod provides long-term protection in rodent models of cerebral ischemia.

Authors:  Ying Wei; Muge Yemisci; Hyung-Hwan Kim; Lai Ming Yung; Hwa Kyoung Shin; Seo-Kyoung Hwang; Shuzhen Guo; Tao Qin; Nafiseh Alsharif; Volker Brinkmann; James K Liao; Eng H Lo; Christian Waeber
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

2.  Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke.

Authors:  Linda Smedbakken; Jesper K Jensen; Jonas Hallén; Dan Atar; James L Januzzi; Bente Halvorsen; Pål Aukrust; Thor Ueland
Journal:  Stroke       Date:  2011-07-14       Impact factor: 7.914

Review 3.  Immune and inflammatory responses to stroke: good or bad?

Authors:  P A McCombe; S J Read
Journal:  Int J Stroke       Date:  2008-11       Impact factor: 5.266

4.  Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke.

Authors:  Arthur Liesz; Wei Zhou; Éva Mracskó; Simone Karcher; Henrike Bauer; Sönke Schwarting; Li Sun; Dunja Bruder; Sabine Stegemann; Adelheid Cerwenka; Clemens Sommer; Alexander H Dalpke; Roland Veltkamp
Journal:  Brain       Date:  2011-03       Impact factor: 13.501

5.  Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice.

Authors:  C Iadecola; K Sugimoto; K Niwa; K Kazama; M E Ross
Journal:  J Cereb Blood Flow Metab       Date:  2001-12       Impact factor: 6.200

6.  Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia.

Authors:  Andreas Hug; Arthur Liesz; Bettina Muerle; Wei Zhou; Julia Ehrenheim; Alexander Lorenz; Alexander Dalpke; Roland Veltkamp
Journal:  Stroke       Date:  2011-09-29       Impact factor: 7.914

Review 7.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

8.  Activation of sphingosine kinase 2 is an endogenous protective mechanism in cerebral ischemia.

Authors:  Waltraud Pfeilschifter; Bożena Czech-Zechmeister; Marian Sujak; Ana Mirceska; Alexander Koch; Abdelhaq Rami; Helmuth Steinmetz; Christian Foerch; Andrea Huwiler; Josef Pfeilschifter
Journal:  Biochem Biophys Res Commun       Date:  2011-08-22       Impact factor: 3.575

9.  CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke.

Authors:  Xuefang Ren; Kozaburo Akiyoshi; Arthur A Vandenbark; Patricia D Hurn; Halina Offner
Journal:  Metab Brain Dis       Date:  2010-11-17       Impact factor: 3.584

10.  Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1.

Authors:  B Engelhardt; F K Conley; P J Kilshaw; E C Butcher
Journal:  Int Immunol       Date:  1995-03       Impact factor: 4.823

View more
  79 in total

1.  Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors:  Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal:  Assay Drug Dev Technol       Date:  2016-07-08       Impact factor: 1.738

2.  Differential effects of aging and sex on stroke induced inflammation across the lifespan.

Authors:  Bharti Manwani; Fudong Liu; Victoria Scranton; Matthew D Hammond; Lauren H Sansing; Louise D McCullough
Journal:  Exp Neurol       Date:  2013-08-29       Impact factor: 5.330

Review 3.  [Experimental therapy approaches for ischemic stroke].

Authors:  C Kleinschnitz; N Plesnila
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

Review 4.  Causes of death among persons who survive an acute ischemic stroke.

Authors:  Shuai Zhang; Wen-Bin He; Nai-Hong Chen
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

Review 5.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

6.  Cellular factors promoting resistance to effective treatment of glioma with oncolytic myxoma virus.

Authors:  Franz J Zemp; Brienne A McKenzie; Xueqing Lun; Karlyne M Reilly; Grant McFadden; V Wee Yong; Peter A Forsyth
Journal:  Cancer Res       Date:  2014-10-21       Impact factor: 12.701

7.  IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke.

Authors:  Shenpeng R Zhang; Marius Piepke; Hannah X Chu; Brad Rs Broughton; Raymond Shim; Connie Hy Wong; Seyoung Lee; Megan A Evans; Antony Vinh; Samy Sakkal; Thiruma V Arumugam; Tim Magnus; Samuel Huber; Mathias Gelderblom; Grant R Drummond; Christopher G Sobey; Hyun Ah Kim
Journal:  JCI Insight       Date:  2018-09-20

8.  Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia.

Authors:  Hannah X Chu; Hyun Ah Kim; Seyoung Lee; Jeffrey P Moore; Christopher T Chan; Antony Vinh; Mathias Gelderblom; Thiruma V Arumugam; Brad R S Broughton; Grant R Drummond; Christopher G Sobey
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

Review 9.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 10.  T cells in organ ischemia reperfusion injury.

Authors:  Jianhua Rao; Ling Lu; Yuan Zhai
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.